Novo Nordisk ADR
NVOHealthcare·Drug Manufacturers - General·Denmark·Large·NYSE·Nov 11 • 3:59 PM ET
41.09+0.39 (0.96%)
2026-11-12 05:20 CET
Market cap
137,482.21 USD m
Revenue, TTM
51,896.99 USD m
Net income, TTM
17,636.87 USD m
Free cash flow, TTM
11,041.77 USD m
EPS diluted, TTM
3.97
P/E
10.35
Price
NVO against its 20, 50 and 200-day averages2050200miss
36.0% under the 52-week high of 64.16 on 23 Jan 2026. 52-week low 35.12 on 30 Mar 2026. Last 15 sessions, 13.9% high to low
Volume 0.96× normal · the line is the 50-bar volume average
Profile
NVO52-week range, 21% of the way up
35.1264.16
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.
| Employees | 68794 |
|---|---|
| IPO | Apr 30, 1981 |
| Beta | 0.71 |
| ATR, 14d | 1.07 |
| Rel volume | 0.96 |
| Short float | 1.14% |
| Insider own | 0.01% |
| Inst own | 9.81% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 137.48B |
| Enterprise Value | 150.87B |
| Income | 17.64B |
| Sales | 51.90B |
| Book/sh | 7.49 |
| Cash/sh | 2.10 |
| Dividend Est. | 1.76 (4.27%) |
| Dividend TTM | 1.80 (4.37%) |
| Dividend Ex-Date | Aug 17, 2026 |
| Dividend Gr. 3/5Y | 26.98% 19.93% |
| Payout | 36.87% |
| Employees | 68794 |
| IPO | Apr 30, 1981 |
Ratios
| P/E | 10.35 |
|---|---|
| Forward P/E | 12.11 |
| PEG | 71.21 |
| P/S | 2.65 |
| P/B | 5.49 |
| P/C | 19.52 |
| P/FCF | 12.45 |
| EV/EBITDA | 5.46 |
| EV/Sales | 2.91 |
| Quick Ratio | 0.64 |
| Current Ratio | 0.84 |
| Debt/Eq | 0.62 |
| LT Debt/Eq | 0.54 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | 3.97 |
|---|---|
| EPS next Y | 3.39 |
| EPS next Q | 0.66 |
| EPS this Y | -5.37% |
| EPS next Y | -1.41% |
| EPS next 5Y | 0.17% |
| EPS past 3/5Y | 26.28% 20.36% |
| Sales past 3/5Y | 23.19% 19.21% |
| EPS Y/Y TTM | 15.62% |
| Sales Y/Y TTM | 11.16% |
| EPS Q/Q | -17.31% |
| Sales Q/Q | 3.83% |
| Earnings | Nov 04 BMO |
| EPS/Sales Surpr. | 19.06% 7.54% |
Ownership
| Insider Own | 0.01% |
|---|---|
| Insider Trans | 0.00% |
| Inst Own | 9.81% |
| Inst Trans | -0.59% |
| ROA | 20.55% |
| ROE | 58.95% |
| ROIC | 34.59% |
| Gross Margin | 82.02% |
| Oper. Margin | 48.35% |
| Profit Margin | 33.98% |
| SMA20 | 3.35% |
| SMA50 | 1.89% |
| SMA200 | -5.26% |
| Trades | - |
Technical
| Shs Outstand | 3.35B |
|---|---|
| Shs Float | 3.35B |
| Short Float | 1.14% |
| Short Ratio | 3.15 |
| Short Interest | 38.29M |
| 52W High | 64.16 -35.96% |
| 52W Low | 35.12 17.00% |
| Volatility | 2.40% 1.78% |
| ATR (14) | 1.07 |
| RSI (14) | 55.87 |
| Beta | 0.71 |
| Rel Volume | 0.96 |
| Avg Volume | 12.16M |
| Volume | 11,707,415 |
Performance
| Perf Week | -2.58% |
|---|---|
| Perf Month | 7.96% |
| Perf Quarter | -12.05% |
| Perf Half Y | -12.72% |
| Perf YTD | -19.24% |
| Perf Year | -16.40% |
| Perf 3Y | -59.39% |
| Perf 5Y | -27.54% |
| Perf 10Y | 145.68% |
| Recom | 2.75 |
| Target Price | 54.57 |
| Prev Close | 40.70 |
| Price | 41.09 |
| Change % | 0.96% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 11, 2026 | Downgrade | MMorgan Stanley | Equal-Weight → Underweight | $40 | -2.7% |
| Aug 27, 2026 | Downgrade | DDeutsche Bank | Hold → Sell | ||
| Aug 12, 2026 | Downgrade | BBerenberg | Buy → Hold | ||
| Mar 26, 2026 | Initiated | WWolfe Research | Peer Perform | ||
| Mar 18, 2026 | Initiated | BBernstein | Underperform | ||
| Mar 18, 2026 | Initiated | BBernstein | Outperform | $175 | +325.9% |
| Mar 10, 2026 | Downgrade | TTD Cowen | Buy → Hold | $42 | +2.2% |
| Mar 03, 2026 | Upgrade | MMorgan Stanley | Underweight → Equal-Weight | $40 | -2.7% |
| Mar 02, 2026 | Downgrade | GGoldman | Buy → Neutral | $41 | -0.2% |
| Feb 24, 2026 | Downgrade | KKepler | Buy → Hold |
Peers
Mkt capHeld by
AUM| Ticker | Company | AUM |
|---|---|---|
| AVDE | Avantis International Equity ETF | AUM: 19.73B |
| PPH | VanEck Pharmaceutical ETF | AUM: 1.09B |
| WCMI | First Trust WCM International Equity ETF | AUM: 2.12B |
| FENI | Fidelity Enhanced International ETF | AUM: 11.73B |
| PID | Invesco International Dividend Achievers ETF | AUM: 881.07M |
| RODM | Hartford Multifactor Developed Markets (ex-US) ETF | AUM: 1.67B |
| AVIV | Avantis International Large Cap Value ETF | AUM: 2.09B |
| APIE | ActivePassive International Equity ETF | AUM: 1.13B |
| OZEM | Roundhill GLP-1 & Weight Loss ETF | AUM: 58.23M |
| AQEC | AQE Core ETF | AUM: 604.49M |
News
latest 14 of 200- The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed. (International Business Times)
- Eli Lilly's Weight-Loss Pill Shows Sleep Apnea Benefits. Can It Gain on Novo? (Barrons.com)
- Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss (MarketWatch)
- FDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugs (Investing.com)
- Palatin's Peptide Is Advancing Toward the Clinic as Big Pharma Pays Billions for Early Peptides (NASDAQ: PTN) (FinanceWire)
- Novo real-world studies link Wegovy 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with MASH at The Liver Meeting (AASLD) 2026 (PR Newswire)
- Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugs (Investing.com)
- Earnings live updates: Moderna's COVID vaccine sales drive revenue growth, raised outlook (Yahoo Finance)
- Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying. (MarketWatch)
- Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly Agreement (Barrons.com)
- Novo Nordisk Raises Guidance A Third Time, But Slowing US Growth Clouds The Upgrade (Earnings Whispers)
- Novo Nordisk Stock Jumps After Outlook Improves (The Wall Street Journal)
- Novo Nordisk CEO: Wegovy pill 'exceeded our expectations' (Yahoo Finance)
- Novo hires new CFO as Wegovy pill hits more markets (CFO Dive)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-04 | 0.870 | 0.731 | 0.570 | 11,904 | 11,070 | 13 |
| 2026Q2 | 2026-08-04 | 0.955 | 0.770 | 0.736 | 12,130 | 10,889 | 15 |
| 2026Q1 | 2026-05-06 | 1.043 | 0.884 | 1.709 | 11,023 | 10,860 | 15 |
| 2025Q4 | 2026-02-04 | 0.954 | 0.923 | 0.942 | 12,503 | 12,128 | 14 |
| 2025Q3 | 2025-11-05 | 0.692 | 0.764 | 0.704 | 11,529 | 11,944 | 13 |
| 2025Q2 | 2025-08-06 | 0.929 | 0.919 | 0.905 | 11,974 | 11,923 | 12 |
| 2025Q1 | 2025-05-07 | 0.995 | 0.915 | 0.916 | 11,897 | 11,695 | 13 |
| 2024Q4 | 2025-02-05 | 0.886 | 0.831 | 0.906 | 11,970 | 11,136 | 13 |
| 2024Q3 | 2024-11-06 | 0.881 | 0.880 | 0.901 | 10,270 | 10,572 | 14 |
| 2024Q2 | 2024-08-07 | 0.657 | 0.708 | 0.648 | 9,976 | 9,988 | 17 |
| 2024Q1 | 2024-05-02 | 0.814 | 0.752 | 0.827 | 9,366 | 9,129 | 13 |
| 2023Q4 | 2024-01-31 | 0.716 | 0.670 | 0.707 | 9,599 | 9,153 | 12 |
| 2023Q3 | 2023-11-02 | 0.711 | 0.680 | 0.731 | 8,355 | 8,172 | 11 |
| 2023Q2 | 2023-08-10 | 0.638 | 0.678 | 0.630 | 8,029 | 8,206 | 13 |
| 2023Q1 | 2023-05-04 | 0.648 | 0.621 | 0.633 | 7,880 | 7,658 | 11 |
| 2022Q4 | 2023-02-01 | 0.433 | 2.909 | 0.412 | 6,953 | 46,832 | 14 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 1.206 | 1.222 | 1.227 | 17,964 | 17,950 |
| 2020FY | 1.454 | 1.457 | 1.377 | 20,503 | 20,626 |
| 2021FY | 1.575 | 1.571 | 1.648 | 21,383 | 21,309 |
| 2022FY | 1.794 | 1.759 | 1.726 | 25,975 | 25,412 |
| 2023FY | 2.714 | 2.673 | 2.701 | 33,848 | 33,469 |
| 2024FY | 3.162 | 3.136 | 3.282 | 40,571 | 39,723 |
| 2025FY | 3.638 | 3.702 | 3.627 | 48,826 | 48,431 |
| 2026FY | - | 3.443 | - | - | 46,328 |
| 2027FY | - | 3.394 | - | - | 47,311 |
| 2028FY | - | 3.657 | - | - | 50,001 |
| 2029FY | - | 3.988 | - | - | 53,391 |
| 2030FY | - | 4.336 | - | - | 55,973 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-06 | 10 | 6 | 3 | 11,784 | 11,109 | 12,503 |
| 2026Q4 | S | 2026-11-05 | 10 | 6 | 3 | 11,793 | 11,109 | 12,503 |
| 2026Q4 | S | 2026-11-04 | 10 | 5 | 4 | 11,705 | 11,109 | 12,503 |
| 2026Q4 | S | 2026-10-31 | 10 | 2 | 5 | 11,415 | 11,109 | 11,860 |
| 2026Q4 | S | 2026-10-29 | 11 | 2 | 5 | 11,414 | 11,109 | 11,860 |
| 2026Q4 | S | 2026-10-23 | 11 | 2 | 4 | 11,440 | 11,140 | 11,860 |
| 2026Q4 | S | 2026-10-20 | 12 | 2 | 3 | 11,581 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-19 | 12 | 3 | 3 | 11,581 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-14 | 12 | 5 | 3 | 11,581 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-13 | 12 | 5 | 3 | 11,579 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-09 | 12 | 6 | 3 | 11,576 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-06 | 12 | 6 | 3 | 11,576 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-05 | 12 | 6 | 4 | 11,531 | 11,140 | 12,691 |
| 2026Q4 | S | 2026-10-02 | 12 | 7 | 3 | 11,550 | 11,140 | 12,691 |
Estimate history
| EPS, annual | 1.167 | 1.261 | 1.227 | 1.377 | 1.648 | 1.726 | 2.701 | 3.282 | 3.483 | 3.9699 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 0.901 | 0.906 | 0.916 | 0.905 | 0.704 | 0.942 | 1.709 | 0.736 | 0.583 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 16936.873 | 17700.962 | 18292.111 | 19412.858 | 22377.745 | 24998.461 | 33700.297 | 42115.001 | 46735.785 | 51896.99 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 10500.229 | 12253.617 | 11016.745 | 11675 | 11739.67 | 12334.36 | 15162.531 | 12211.264 | 12188.838 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 3813.128 | 3714 | 3630 | 3551 | 3483.8 | 3424.928 | 3383.428 | 3366 | 3369.128 | 3345.879 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 3338.428 | 3366 | 3366 | 3366 | 3368.479 | 3369.128 | 3369.128 | 3345.879 | 3345.879 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 51,896.99 | 46,735.79 | 42,115.00 | 33,700.30 | 24,998.46 | 22,377.74 | 19,412.86 | 18,292.11 | 17,700.96 |
| Cost of Goods Sold Incl. D&A | 9,332.48 | 9,187.80 | 6,802.43 | 5,631.78 | 4,375.87 | 4,019.25 | 3,534.03 | 3,176.88 | 2,992.50 |
| Gross Profit | 42,564.51 | 37,547.98 | 35,312.57 | 28,068.52 | 20,622.59 | 18,358.49 | 15,878.83 | 15,115.23 | 14,708.46 |
| Selling, General and Administrative Excl. Other | 17,471.49 | 17,287.30 | 15,130.79 | 13,067.84 | 10,109.35 | 8,980.50 | 7,602.22 | 7,161.18 | 7,395.78 |
| Research and Development | 8,024.02 | 6,838.34 | 5,513.90 | 4,261.92 | 3,074.20 | 2,589.33 | 2,097.02 | 1,936.53 | 2,147.59 |
| Other Operating Expense | - | -156.51 | -34.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 25,093.02 | 20,417.19 | 20,216.59 | 15,000.67 | 10,513.24 | 9,377.99 | 8,276.61 | 7,954.05 | 7,312.68 |
| Interest Expense | - | 638.74 | 240.30 | 107.23 | 78.97 | 65.32 | 82.58 | 75.10 | 24.85 |
| Unusual Expense | - | 1,454.71 | 899.72 | 10.16 | 356.85 | -146.70 | 238.86 | 454.08 | 251.99 |
| Net Income Before Taxes | 22,543.94 | 19,741.25 | 18,445.57 | 15,176.10 | 9,783.16 | 9,393.57 | 8,101.97 | 7,299.10 | 7,534.75 |
| Income Taxes | 4,907.07 | 4,250.11 | 3,800.03 | 3,045.72 | 1,912.38 | 1,799.60 | 1,680.92 | 1,439.43 | 1,422.49 |
| Consolidated Net Income | 17,636.87 | 15,489.78 | 14,645.54 | 12,142.12 | 7,844.07 | 7,590.16 | 6,443.83 | 5,839.13 | 6,114.16 |
| Net Income From Continuing Operations | 17,636.87 | 15,489.78 | 14,645.54 | 12,142.12 | 7,844.07 | 7,590.16 | 6,443.83 | 5,839.13 | 6,114.16 |
| Net Income | 17,636.87 | 15,489.78 | 14,645.54 | 12,142.12 | 7,844.07 | 7,590.16 | 6,443.83 | 5,839.13 | 6,114.16 |
| EPS (Recurring) | 3.99 | 3.71 | 3.42 | 2.70 | 1.78 | 1.63 | 1.41 | 1.29 | 1.30 |
| EPS (Basic, Before Extraordinaries) | 3.97 | 3.49 | 3.29 | 2.71 | 1.73 | 1.65 | 1.38 | 1.23 | 1.26 |
| EPS (Diluted) | 3.97 | 3.48 | 3.28 | 2.70 | 1.73 | 1.65 | 1.38 | 1.23 | 1.26 |
| EBITDA | 27,624.93 | 22,634.94 | 21,455.81 | 16,161.30 | 11,445.91 | 10,222.08 | 9,083.42 | 8,655.48 | 7,915.58 |
| Non-Operating Income (Expense) | -137.52 | 1,417.51 | -630.99 | 292.81 | -294.27 | -65.80 | 146.81 | -125.77 | 498.91 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 169.26 | 258.93 | 243.21 | 169.58 | 128.93 | 98.17 | 42.45 | 51.11 |
| Price To Earnings Ratio | 10.34 | 10.34 | - | - | 40.07 | 33.84 | 25.35 | 23.52 | 18.17 |
| Price To Sales Ratio | 3.23 | 4.84 | 9.12 | 13.80 | 12.30 | 11.53 | 8.42 | 7.53 | 6.31 |
| Gross Margin | 82.02 | 80.34 | 83.85 | 83.29 | 82.50 | 82.04 | 81.80 | 82.63 | 83.09 |
| Operating Margin | 48.35 | 43.69 | 48.00 | 44.51 | 42.06 | 41.91 | 42.63 | 43.48 | 41.31 |
| Net Margin | 33.98 | 33.14 | 34.78 | 36.03 | 31.38 | 33.92 | 33.19 | 31.92 | 34.54 |
| Shares Outstanding | 3,345.88 | 3,369.13 | 3,366.00 | 3,383.43 | 3,424.93 | 3,483.80 | 3,551.00 | 3,630.00 | 3,714.00 |
| Market Capitalization | 137,482.21 | 137,482.21 | 287,171.75 | 350,238.25 | 230,873.62 | 195,092.80 | 124,018.68 | 105,052.20 | 85,551.99 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12,188.84 | 12,211.26 | 15,162.53 | 12,334.36 | 11,739.67 | 11,675.00 | 11,016.74 | 12,253.62 |
| Cost of Goods Sold Incl. D&A | 2,181.82 | 2,660.44 | 2,129.45 | 2,360.77 | 2,803.39 | 1,951.38 | 1,818.56 | 1,862.58 |
| Gross Profit | 10,007.02 | 9,550.82 | 13,033.08 | 9,973.59 | 8,936.28 | 9,723.62 | 9,198.19 | 10,391.04 |
| Selling, General and Administrative Excl. Other | 4,532.32 | 4,261.99 | 3,676.67 | 5,000.51 | 5,209.85 | 4,639.04 | 3,727.41 | 4,874.25 |
| Research and Development | 2,347.88 | 1,782.81 | 1,610.48 | 2,282.85 | 2,410.22 | 1,775.78 | 1,454.28 | 1,973.84 |
| Operating Income | 5,474.70 | 5,288.83 | 9,356.41 | 4,973.08 | 3,726.42 | 5,084.58 | 5,470.77 | 5,516.79 |
| Interest Expense | 174.53 | 233.37 | 547.95 | - | - | 753.15 | 731.23 | 728.36 |
| Unusual Expense | 1,657.91 | 1,042.24 | 3.60 | - | - | - | - | - |
| Net Income Before Taxes | 3,298.89 | 4,181.25 | 9,736.17 | 5,327.63 | 3,995.43 | 5,135.16 | 5,224.72 | 5,085.04 |
| Income Taxes | 722.45 | 915.75 | 2,132.12 | 1,136.75 | 862.91 | 1,109.21 | 1,128.52 | 1,047.84 |
| Consolidated Net Income | 2,576.44 | 3,265.50 | 7,604.05 | 4,190.88 | 3,132.52 | 4,025.95 | 4,096.20 | 4,037.20 |
| Net Income From Continuing Operations | 2,576.44 | 3,265.50 | 7,604.05 | 4,190.88 | 3,132.52 | 4,025.95 | 4,096.20 | 4,037.20 |
| Net Income | 2,576.44 | 3,265.50 | 7,604.05 | 4,190.88 | 3,132.52 | 4,025.95 | 4,096.20 | 4,037.20 |
| EPS (Recurring) | 0.84 | 0.90 | 1.71 | 0.94 | 0.70 | 0.91 | 0.92 | 0.91 |
| EPS (Basic, Before Extraordinaries) | 0.58 | 0.74 | 1.71 | 0.94 | 0.70 | 0.91 | 0.92 | 0.91 |
| EPS (Diluted) | 0.58 | 0.74 | 1.71 | 0.94 | 0.70 | 0.91 | 0.92 | 0.91 |
| EBITDA | 6,028.78 | 5,849.70 | 9,906.55 | 5,839.90 | 4,941.01 | 5,818.74 | 6,011.12 | 6,260.17 |
| Non-Operating Income (Expense) | -343.37 | 168.03 | 931.30 | 354.55 | 269.00 | 803.73 | 485.18 | 296.60 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price To Earnings Ratio | 10.34 | 11.24 | 10.58 | 14.80 | 15.26 | 20.43 | 21.11 | - |
| Price To Sales Ratio | 3.23 | 4.13 | 3.21 | 4.84 | 5.29 | 6.75 | 7.12 | 9.11 |
| Gross Margin | 82.10 | 78.21 | 85.96 | 80.86 | 76.12 | 83.29 | 83.49 | 84.80 |
| Operating Margin | 44.92 | 43.31 | 61.71 | 40.32 | 31.74 | 43.55 | 49.66 | 45.02 |
| Net Margin | 21.14 | 26.74 | 50.15 | 33.98 | 26.68 | 34.48 | 37.18 | 32.95 |
| Shares Outstanding | 3,345.88 | 3,345.88 | 3,369.13 | 3,369.13 | 3,368.48 | 3,366.00 | 3,366.00 | 3,366.00 |
| Market Capitalization | 137,482.21 | 160,981.56 | 123,815.53 | 171,394.88 | 186,786.55 | 232,330.29 | 233,608.66 | 287,171.75 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 4,239.57 | 3,653.08 | 4,479.61 | 3,383.25 | 2,673.45 | 2,096.98 | 2,324.62 | 2,395.55 | 3,412.04 |
| Short Term Receivables | 11,903.89 | 10,386.86 | 9,956.95 | 7,391.09 | 6,385.38 | 4,606.39 | 3,863.30 | 3,645.71 | 3,406.72 |
| Inventories | 7,802.85 | 5,672.21 | 4,713.89 | 3,500.08 | 3,000.04 | 3,046.93 | 2,649.99 | 2,502.47 | 2,479.36 |
| Other Current Assets | 3,170.64 | 2,753.42 | 1,542.90 | 1,253.18 | 1,028.55 | 1,067.31 | 544.09 | 504.60 | 391.59 |
| Total Current Assets | 27,116.96 | 22,465.56 | 20,693.35 | 15,527.60 | 13,087.42 | 10,817.62 | 9,382.00 | 9,048.32 | 9,689.70 |
| Net Property, Plant & Equipment | 32,765.90 | 22,450.57 | 13,479.00 | 9,568.37 | 8,464.81 | 8,263.17 | 7,593.66 | 6,417.18 | 5,684.63 |
| Total Investments and Advances | 394.21 | 371.72 | 246.43 | 192.74 | 220.33 | 270.90 | 271.59 | 271.60 | 192.73 |
| Long-Term Note Receivable | - | - | - | - | - | - | - | - | 91.45 |
| Intangible Assets | 20,449.87 | 15,388.39 | 8,951.23 | 7,379.03 | 6,600.82 | 3,395.58 | 876.52 | 788.15 | 536.26 |
| Deferred Tax Assets | 3,718.32 | 3,422.57 | 3,020.00 | 1,926.99 | 1,325.94 | 964.08 | 619.05 | 443.17 | 313.04 |
| Other Assets | 922.07 | 557.65 | 211.90 | 29.56 | 40.82 | 110.79 | 126.33 | 0.00 | 0.00 |
| Total Assets | 85,367.32 | 64,656.47 | 46,601.91 | 34,624.31 | 29,740.15 | 23,822.14 | 18,869.16 | 16,968.42 | 16,507.81 |
| Short Term Debt Incl. Current Port. of LT Debt | 1,889.58 | 1,820.85 | 959.94 | 210.39 | 2,092.27 | 1,226.10 | 221.42 | 78.89 | 273.21 |
| Accounts Payable | 3,106.80 | 2,380.03 | 3,794.41 | 2,236.99 | 1,356.22 | 939.76 | 955.08 | 1,034.93 | 904.78 |
| Income Tax Payable | 1,323.35 | 1,349.14 | 1,054.48 | 1,017.67 | 559.31 | 643.22 | 632.72 | 706.19 | 684.15 |
| Other Current Liabilities | 27,591.36 | 24,667.44 | 19,331.39 | 13,891.80 | 11,208.13 | 8,742.34 | 7,051.07 | 6,477.22 | 5,727.05 |
| Total Current Liabilities | 33,911.10 | 30,217.45 | 25,140.22 | 17,356.86 | 15,215.93 | 11,551.41 | 8,860.30 | 8,297.24 | 7,589.19 |
| Long Term Debt | 18,702.59 | 12,451.96 | 3,041.93 | 3,490.03 | 1,981.73 | 476.21 | 452.01 | 0.00 | 0.00 |
| Provision for Risks Charges | 1,036.39 | 1,094.90 | 1,095.23 | 768.10 | 864.49 | 973.95 | 893.35 | 712.02 | 748.02 |
| Deferred Tax Liabilities | 1,039.53 | 765.80 | 1,505.85 | 1,013.37 | 805.93 | 411.28 | 12.02 | 18.08 | 136.44 |
| Other Liabilities | 165.26 | 202.18 | 28.01 | 14.35 | 55.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 54,854.87 | 44,732.28 | 30,811.24 | 22,642.71 | 18,923.13 | 13,412.84 | 10,217.67 | 9,027.34 | 8,473.65 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 30,512.45 | 19,924.18 | 15,790.67 | 11,981.60 | 10,817.02 | 10,409.30 | 8,651.49 | 7,941.08 | 8,034.16 |
| Total Shareholders Equity | 30,512.45 | 19,924.18 | 15,790.67 | 11,981.60 | 10,817.02 | 10,409.30 | 8,651.49 | 7,941.08 | 8,034.16 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 30,512.45 | 19,924.18 | 15,790.67 | 11,981.60 | 10,817.02 | 10,409.30 | 8,651.49 | 7,941.08 | 8,034.16 |
| Total Liabilities & Stockholders Equity | 85,367.32 | 64,656.47 | 46,601.91 | 34,624.31 | 29,740.15 | 23,822.14 | 18,869.16 | 16,968.42 | 16,507.81 |
| Book Value Per Share | 6.87 | 4.49 | 3.54 | 2.66 | 2.37 | 2.25 | 1.84 | 1.66 | 1.64 |
| Tangible Book Value Per Share | 2.99 | 1.35 | 2.02 | 1.34 | 1.21 | 1.98 | 2.14 | 1.93 | 1.97 |
| Full-Time Employees | 68,794 | 76,302 | 63,370 | 54,393 | 47,792 | 45,323 | 43,258 | 43,202 | 42,076 |
| Price to Book Ratio | 5.49 | - | - | 30.05 | 23.60 | 15.52 | 15.74 | 13.89 | 17.66 |
| Return on Assets | 20.65 | 26.33 | 29.90 | 24.37 | 28.34 | 30.19 | 32.59 | 36.53 | 38.11 |
| Return on Equity | 61.42 | 82.01 | 87.44 | 68.81 | 71.52 | 67.61 | 70.38 | 76.55 | 79.99 |
| Return on Invested Capital | 31.47 | 45.24 | 64.47 | 50.70 | 59.30 | 59.20 | 64.14 | 76.99 | 71.97 |
| Quick Ratio | 0.57 | 0.56 | 0.64 | 0.69 | 0.66 | 0.67 | 0.76 | 0.79 | 0.95 |
| Current Ratio | 0.80 | 0.74 | 0.82 | 0.89 | 0.86 | 0.94 | 1.06 | 1.09 | 1.28 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 17,566.15 | 15,489.78 | 14,645.54 | 12,142.12 | 7,844.07 | 7,590.16 | 6,443.83 | 5,839.13 | 6,114.16 |
| Depreciation | 2,524.71 | 2,217.75 | 1,239.22 | 1,160.63 | 932.67 | 844.09 | 806.82 | 701.43 | 602.90 |
| Other Funds (Non Cash) | -616.39 | -84.08 | 2,078.17 | 4,923.86 | 3,659.20 | 1,926.27 | 1,193.25 | 1,205.57 | 1,033.27 |
| Funds from Operations | 19,474.47 | 17,445.17 | 17,167.63 | 17,578.90 | 11,898.26 | 10,117.66 | 8,612.88 | 7,523.96 | 7,598.38 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 187.25 | 565.10 | 375.46 | -1,776.71 | -753.82 | -1,375.72 | -665.67 | -507.89 | -533.41 |
| Cash from Operating Activities | 19,661.73 | 18,010.27 | 17,543.10 | 15,802.19 | 11,144.44 | 8,741.94 | 7,947.21 | 7,016.07 | 7,064.97 |
| Capital Expenditures | -12,683.50 | -13,626.63 | -7,440.97 | -5,643.68 | -2,084.17 | -1,173.72 | -3,376.67 | -1,683.63 | -1,964.29 |
| Net Assets From Acquisitions | 0.00 | 0.00 | -11,915.49 | 0.00 | -999.49 | -2,905.77 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | 152.40 | 151.82 | 0.00 | 0.00 | 0.00 | 0.00 | 1.07 | 0.60 | 2.06 |
| Purchase or Sale of Investments | -252.48 | 1,504.76 | 663.77 | -724.90 | -436.53 | -944.22 | -58.11 | -45.27 | 47.17 |
| Purchase of Investments | -282.03 | -109.33 | -2,873.48 | -1,928.19 | -1,375.27 | -1,130.49 | -59.95 | -67.46 | -39.25 |
| Sale Or Maturity of Investments | 29.55 | 1,614.09 | 3,537.25 | 1,203.29 | 938.75 | 186.27 | 1.84 | 22.19 | 86.42 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -12,783.58 | -11,970.05 | -18,692.69 | -6,368.58 | -3,520.19 | -5,023.71 | -3,433.71 | -1,728.31 | -1,915.07 |
| Cash Dividends Paid | -8,114.93 | -7,827.45 | -6,401.30 | -4,609.29 | -3,574.58 | -3,419.76 | -3,076.95 | -2,909.59 | -3,014.98 |
| Change in Capital Stock | -1,557.30 | -209.89 | -2,926.70 | -4,341.87 | -3,402.65 | -3,090.77 | -2,577.50 | -2,298.71 | -2,463.99 |
| Repurchase of Common Pref Stock | -1,557.30 | -209.89 | -2,926.70 | -4,341.87 | -3,402.65 | -3,090.77 | -2,577.50 | -2,298.71 | -2,463.99 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | - | 3,968.85 | 10,800.30 | -2.76 | -199.19 | 2,458.85 | 723.63 | -111.08 | 14.88 |
| Change in Long Term Debt | - | 4,696.50 | 10,029.47 | 0.00 | 1,570.93 | - | 0.00 | - | 0.00 |
| Issuance of Long Term Debt | - | 12,201.71 | 10,732.69 | 0.00 | 1,570.93 | - | 0.00 | - | 0.00 |
| Reduction of Long Term Debt | - | -7,505.21 | -703.21 | 0.00 | - | - | 0.00 | - | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -4,959.66 | -4,295.78 | 1,266.77 | -9,164.02 | -7,317.41 | -4,051.68 | -4,930.82 | -5,319.39 | -5,464.09 |
| Exchange Rate Effect | -6.81 | -109.93 | 65.99 | -17.27 | -33.62 | 93.93 | -69.73 | -1.05 | 6.96 |
| Net Change in Cash | 1,911.67 | 1,634.51 | 183.16 | 252.32 | 273.22 | -239.51 | -487.06 | -32.68 | -307.23 |
| Free Cash Flow | 11,041.77 | 8,916.07 | 10,703.25 | 12,057.82 | 9,428.57 | 7,735.10 | 7,056.44 | 5,677.07 | 5,539.75 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 57.29 | 207.88 | 89.24 | 62.43 | 52.53 | 59.77 | 41.07 | 49.75 | 44.24 |
| Deferred Taxes & Investment Tax Credit | - | -178.29 | -795.30 | -647.71 | -537.68 | -242.85 | 168.98 | -222.17 | -151.95 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 7,042.82 | 6,880.09 | 3,334.57 | 4,239.57 | 5,128.92 | 2,979.01 |
| Short Term Receivables | 15,037.57 | 14,362.34 | 13,538.56 | 11,903.89 | 12,592.40 | 11,417.92 |
| Inventories | 7,780.20 | 7,854.39 | 7,918.09 | 7,802.85 | 7,477.65 | 7,182.73 |
| Other Current Assets | 2,163.96 | 2,823.65 | 2,549.73 | 3,170.64 | 3,431.40 | 4,019.79 |
| Total Current Assets | 32,024.55 | 31,920.46 | 27,340.95 | 27,116.96 | 28,630.37 | 25,599.45 |
| Net Property, Plant & Equipment | 36,585.71 | 35,447.84 | 33,918.34 | 32,765.90 | 30,418.71 | 28,439.85 |
| Total Investments and Advances | 380.01 | 356.38 | 345.55 | 394.21 | 428.94 | 415.05 |
| Intangible Assets | 16,983.04 | 18,668.86 | 20,031.15 | 20,449.87 | 16,777.96 | 16,971.27 |
| Deferred Tax Assets | 4,084.36 | 3,620.68 | 3,667.78 | 3,718.32 | 3,584.56 | 3,736.27 |
| Other Assets | 980.03 | 983.18 | 923.92 | 922.07 | 799.18 | 698.42 |
| Total Assets | 91,037.69 | 90,997.40 | 86,227.68 | 85,367.32 | 80,639.72 | 75,860.32 |
| Short Term Debt Incl. Current Port. of LT Debt | 2,543.21 | 2,804.07 | 4,195.58 | 1,889.58 | 1,894.28 | 1,882.22 |
| Accounts Payable | 2,312.10 | 2,231.72 | 2,282.51 | 3,106.80 | 3,762.75 | 4,437.84 |
| Income Tax Payable | 4,191.48 | 3,129.40 | 2,490.05 | 1,323.35 | 3,515.77 | 2,663.24 |
| Other Current Liabilities | 28,855.19 | 28,403.03 | 25,749.53 | 27,591.36 | 27,717.70 | 23,667.52 |
| Total Current Liabilities | 37,901.98 | 36,568.22 | 34,717.67 | 33,911.10 | 36,890.50 | 32,650.81 |
| Long Term Debt | 17,889.98 | 18,628.63 | 18,375.43 | 18,702.59 | 14,037.90 | 13,736.27 |
| Provision for Risks Charges | 1,356.39 | 1,068.68 | 839.89 | 1,036.39 | 1,505.95 | 1,486.36 |
| Deferred Tax Liabilities | 544.41 | 653.26 | 772.20 | 1,039.53 | 1,458.88 | 1,541.27 |
| Other Liabilities | 251.62 | 233.86 | 211.40 | 165.26 | 2.99 | 2.67 |
| Total Liabilities | 57,944.37 | 57,152.65 | 54,916.58 | 54,854.87 | 53,896.23 | 49,417.38 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 33,093.32 | 33,844.75 | 31,311.10 | 30,512.45 | 26,743.48 | 26,442.93 |
| Total Shareholders Equity | 33,093.32 | 33,844.75 | 31,311.10 | 30,512.45 | 26,743.48 | 26,442.93 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 33,093.32 | 33,844.75 | 31,311.10 | 30,512.45 | 26,743.48 | 26,442.93 |
| Total Liabilities & Stockholders Equity | 91,037.69 | 90,997.40 | 86,227.68 | 85,367.32 | 80,639.72 | 75,860.32 |
| Book Value Per Share | 7.49 | 7.66 | 7.05 | 6.87 | 6.02 | 5.95 |
| Tangible Book Value Per Share | 4.81 | 4.54 | 3.35 | 2.99 | 2.96 | 2.81 |
| Full-Time Employees | - | - | - | 68,794 | 78,554 | 78,387 |
| Price to Book Ratio | 5.49 | 6.80 | 5.35 | 8.45 | 9.32 | 15.28 |
| Return on Assets | 20.55 | 21.81 | 24.14 | 20.59 | 21.82 | 25.09 |
| Return on Equity | 58.95 | 60.35 | 73.79 | 61.25 | 68.29 | 75.93 |
| Return on Invested Capital | 5.05 | 6.22 | 15.30 | 8.52 | 7.68 | 10.02 |
| Quick Ratio | 0.64 | 0.66 | 0.56 | 0.57 | 0.57 | 0.56 |
| Current Ratio | 0.84 | 0.87 | 0.79 | 0.80 | 0.78 | 0.78 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 2,541.89 | 3,279.38 | 7,604.05 | 4,140.83 | 3,321.83 | 3,992.82 |
| Depreciation | 553.71 | 560.17 | 553.74 | 857.09 | 1,218.31 | 721.36 |
| Other Funds (Non Cash) | 3,069.41 | 2,436.26 | 711.44 | -6,833.49 | 3,588.78 | -2,133.04 |
| Funds from Operations | 6,165.01 | 6,275.81 | 8,869.23 | -1,835.57 | 8,128.93 | 2,581.14 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 224.27 | 2,087.91 | -5,203.99 | 3,079.07 | -812.22 | 616.52 |
| Cash from Operating Activities | 6,389.27 | 8,363.72 | 3,665.23 | 1,243.50 | 7,316.71 | 3,197.66 |
| Capital Expenditures | -2,105.93 | -2,001.96 | -1,885.31 | -6,690.30 | -2,494.94 | -2,436.95 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 152.40 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -266.86 | -6.74 | 10.18 | 10.93 | 52.30 | 331.65 |
| Purchase of Investments | -266.75 | -14.71 | 0.00 | -0.56 | -7.70 | -85.27 |
| Sale Or Maturity of Investments | -0.10 | 7.97 | 10.18 | 11.50 | 60.00 | 416.92 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -2,372.79 | -2,008.70 | -1,875.13 | -6,526.96 | -2,442.64 | -2,105.31 |
| Cash Dividends Paid | -2,548.48 | 3.81 | -5,529.88 | -40.38 | -2,706.36 | -137.43 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -633.07 | -547.31 | -375.84 | -1.08 | -7.51 | -6.40 |
| Repurchase of Common Pref Stock | -633.07 | -547.31 | -375.84 | -1.08 | -7.51 | -6.40 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -915.48 | -1,150.25 | 2,309.07 | - | -88.62 | -2,786.23 |
| Net Financing Active Other Cash Flow | 0.00 | -1,013.99 | 1,013.99 | 0.00 | 0.00 | -921.77 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -4,097.03 | -2,707.73 | -2,582.66 | 4,427.76 | -2,802.49 | -3,851.83 |
| Exchange Rate Effect | 12.80 | 8.17 | -43.22 | 15.44 | 4.66 | -118.33 |
| Net Change in Cash | -67.75 | 3,655.46 | -835.78 | -840.26 | 2,076.24 | -2,877.81 |
| Free Cash Flow | 4,352.90 | 6,381.40 | 1,893.93 | -1,586.46 | 5,106.66 | 1,001.08 |
| Price to Free Cash Flow | 57.29 | 60.37 | - | 207.17 | 112.71 | 143.42 |
Revenue breakdown
| APAC | 2024: 2.53B 2025: 3.13B |
|---|---|
| China | 2024: 2.68B 2025: 2.82B |
| EUCAN | 2024: 8.35B 2025: 9.99B |
| Emerging Markets | 2024: 4.28B 2025: 4.60B |
| United States | 2024: 24.28B 2025: 26.17B |
| Obesity and Diabetes care | 2024: 39.42B 2025: 43.75B |
| Rare Disease | 2024: 2.70B 2025: 2.96B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 1.14% | 38.3M | 3345.7M | 12.91M |
| 2026-10-15 | 1.12% | 37.4M | 3345.7M | 12.77M |
| 2026-09-30 | 0.95% | 31.6M | 3345.7M | 12.35M |
| 2026-09-15 | 0.79% | 26.3M | 3345.7M | 11.39M |
| 2026-08-31 | 0.95% | 31.6M | 3345.7M | 12.28M |
| 2026-08-14 | 1.01% | 33.8M | 3345.7M | 12.33M |
| 2026-07-31 | 0.88% | 29.4M | 3345.7M | 12.74M |
| 2026-07-15 | 0.93% | 31.1M | 3357.9M | 14.16M |
| 2026-06-30 | 0.83% | 27.8M | 3357.9M | 15.18M |
| 2026-06-15 | 0.73% | 24.5M | 3357.9M | 16.05M |
| 2026-05-29 | 0.67% | 22.7M | 3369.1M | 17.08M |
| 2026-05-15 | 0.64% | 21.7M | 3369.1M | 20.17M |
| 2026-04-30 | 0.42% | 14.0M | 3369.0M | 22.22M |
| 2026-04-15 | 0.51% | 17.0M | 3369.0M | 23.13M |
| 2026-03-31 | 0.59% | 19.9M | 3368.7M | 24.20M |
| 2026-03-13 | 0.73% | 24.7M | 3368.7M | 24.10M |
| 2026-02-27 | 0.84% | 28.3M | 3368.7M | 22.86M |
| 2026-02-13 | 0.80% | 27.0M | 3368.7M | 21.51M |
| 2026-01-30 | 0.94% | 31.7M | 3369.0M | 20.58M |
| 2026-01-15 | 0.84% | 28.2M | 3368.5M | 18.58M |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 25.00 | 15.70 | 16.35 | 15.80 | 4.479 | 8.00 | 14.00 | 0.996 | -0.023 | 0.000 |
| call | 28.00 | 12.30 | 13.45 | 12.54 | 3.908 | 10.00 | 11.00 | 0.995 | -0.022 | 0.000 |
| call | 29.00 | 11.20 | 12.55 | 11.55 | 3.865 | 10.00 | 13.00 | 0.995 | -0.022 | 0.000 |
| call | 30.00 | 10.25 | 11.35 | 10.62 | 3.074 | 6.00 | 9.00 | 0.994 | -0.022 | 0.000 |
| call | 31.00 | 9.10 | 10.35 | 9.45 | 2.815 | 11.00 | 7.00 | 0.994 | -0.022 | 0.001 |
| call | 32.00 | 8.20 | 9.35 | 8.49 | 2.561 | 9.00 | 7.00 | 0.993 | -0.021 | 0.001 |
| call | 33.00 | 7.25 | 8.55 | 7.49 | 2.724 | 11.00 | 6.00 | 0.992 | -0.021 | 0.001 |
| call | 33.50 | 6.75 | 7.85 | 6.99 | 2.189 | 8.00 | 6.00 | 0.992 | -0.021 | 0.001 |
| call | 34.00 | 6.25 | 7.35 | 6.48 | 2.067 | 5.00 | 10.00 | 0.991 | -0.021 | 0.001 |
| call | 34.50 | 6.00 | 6.85 | 6.14 | 1.946 | 5.00 | 13.00 | 0.990 | -0.020 | 0.001 |
| call | 35.00 | 5.50 | 6.30 | 5.60 | 1.922 | 23.00 | 6.00 | 0.990 | -0.020 | 0.001 |
| call | 35.50 | 5.10 | 6.70 | 5.22 | 2.536 | 5.00 | 4.00 | 0.989 | -0.020 | 0.001 |
| call | 36.00 | 4.60 | 5.85 | 5.39 | 2.861 | 8.00 | 0.00 | 0.988 | -0.019 | 0.001 |
| call | 36.50 | 4.30 | 4.85 | 4.31 | 1.462 | 4.00 | 2.00 | 0.978 | -0.034 | 0.002 |
| call | 37.00 | 3.45 | 4.35 | 3.96 | 1.341 | 17.00 | 0.00 | 0.976 | -0.033 | 0.002 |
| call | 37.50 | 3.40 | 3.85 | 3.32 | 1.219 | 222 | 2.00 | 0.968 | -0.040 | 0.002 |
| call | 38.00 | 2.28 | 3.35 | 2.71 | 1.096 | 74.00 | 1.00 | 0.932 | -0.078 | 0.004 |
| call | 38.50 | 2.47 | 2.86 | 2.50 | 0.985 | 88.00 | 23.00 | 0.916 | -0.083 | 0.004 |
| call | 39.00 | 2.05 | 2.25 | 2.22 | 0.704 | 213 | 9.00 | 0.909 | -0.073 | 0.005 |
| call | 39.50 | 1.17 | 1.89 | 0.93 | 0.760 | 158 | 10.00 | 0.862 | -0.091 | 0.006 |
| call | 40.00 | 1.12 | 1.43 | 1.30 | 0.660 | 1,615 | 167 | 0.783 | -0.116 | 0.009 |
| call | 40.50 | 0.79 | 0.92 | 0.81 | 0.523 | 310 | 63.00 | 0.681 | -0.129 | 0.010 |
| call | 41.00 | 0.46 | 0.58 | 0.52 | 0.473 | 1,906 | 525 | 0.537 | -0.138 | 0.012 |
| call | 41.50 | 0.24 | 0.31 | 0.29 | 0.424 | 649 | 876 | 0.372 | -0.121 | 0.011 |
| call | 42.00 | 0.12 | 0.14 | 0.14 | 0.388 | 4,444 | 1,152 | 0.288 | -0.143 | 0.010 |
| call | 42.50 | 0.03 | 0.11 | 0.05 | 0.463 | 3,550 | 99.00 | 0.275 | -0.201 | 0.010 |
| call | 43.00 | 0.03 | 0.04 | 0.03 | 0.456 | 1,704 | 235 | 0.153 | -0.114 | 0.007 |
| call | 43.50 | 0.01 | 0.09 | 0.01 | 0.542 | 2,051 | 13.00 | 0.156 | -0.147 | 0.007 |
| call | 44.00 | 0.00 | 0.02 | 0.01 | 0.514 | 730 | 127 | 0.098 | -0.097 | 0.005 |
| call | 44.50 | 0.00 | 0.06 | 0.01 | 0.591 | 692 | 7.00 | 0.063 | -0.071 | 0.004 |
| call | 45.00 | 0.00 | 0.25 | 0.01 | 0.659 | 4,267 | 23.00 | 0.035 | -0.043 | 0.002 |
| call | 45.50 | 0.00 | 0.01 | 0.01 | 0.725 | 242 | 19.00 | 0.025 | -0.034 | 0.002 |
| call | 46.00 | 0.00 | 0.22 | 0.01 | 0.714 | 412 | 9.00 | 0.014 | -0.020 | 0.001 |
| call | 46.50 | 0.00 | 0.95 | 0.01 | 0.772 | 85.00 | 0.00 | 0.013 | -0.020 | 0.001 |
| call | 47.00 | 0.00 | 0.45 | 0.01 | 0.829 | 857 | 0.00 | 0.012 | -0.021 | 0.001 |
| call | 48.00 | 0.00 | 0.02 | 0.01 | 0.943 | 60.00 | 0.00 | 0.011 | -0.021 | 0.001 |
| call | 49.00 | 0.00 | 2.13 | 0.06 | 1.048 | 52.00 | 0.00 | 0.010 | -0.022 | 0.001 |
| call | 50.00 | 0.00 | 0.01 | 0.02 | 1.167 | 14.00 | 0.00 | 0.009 | -0.020 | 0.001 |
| call | 51.00 | 0.00 | 2.13 | 0.00 | 1.252 | 0.00 | 0.00 | 0.008 | -0.023 | 0.001 |
| call | 52.00 | 0.00 | 0.75 | 0.04 | 1.349 | 1.00 | 0.00 | 0.008 | -0.023 | 0.001 |
| call | 55.00 | 0.00 | 0.27 | 0.01 | 1.624 | 189 | 0.00 | 0.007 | -0.024 | 0.001 |
| put | 25.00 | 0.00 | 0.15 | 0.01 | 2.731 | 1.00 | 0.00 | -0.004 | -0.025 | 0.000 |
| put | 28.00 | 0.00 | 2.13 | 0.06 | 2.156 | 21.00 | 0.00 | -0.005 | -0.024 | 0.000 |
| put | 29.00 | 0.00 | 2.13 | 0.46 | 1.976 | 3.00 | 0.00 | -0.005 | -0.024 | 0.000 |
| put | 30.00 | 0.00 | 2.13 | 0.09 | 1.802 | 56.00 | 0.00 | -0.006 | -0.023 | 0.000 |
| put | 31.00 | 0.00 | 2.13 | 0.04 | 1.632 | 202 | 0.00 | -0.006 | -0.023 | 0.001 |
| put | 32.00 | 0.00 | 2.13 | 0.06 | 1.466 | 540 | 0.00 | -0.007 | -0.023 | 0.001 |
| put | 33.00 | 0.00 | 2.13 | 0.01 | 1.304 | 173 | 0.00 | -0.008 | -0.022 | 0.001 |
| put | 33.50 | 0.00 | 1.55 | 0.95 | 1.225 | 66.00 | 0.00 | -0.008 | -0.022 | 0.001 |
| put | 34.00 | 0.00 | 0.69 | 0.01 | 1.145 | 714 | 0.00 | -0.009 | -0.022 | 0.001 |
| put | 34.50 | 0.00 | 1.35 | 0.08 | 1.067 | 2.00 | 0.00 | -0.009 | -0.021 | 0.001 |
| put | 35.00 | 0.00 | 0.35 | 0.01 | 0.989 | 431 | 0.00 | -0.010 | -0.021 | 0.001 |
| put | 35.50 | 0.00 | 1.00 | 0.02 | 0.912 | 419 | 0.00 | -0.011 | -0.021 | 0.001 |
| put | 36.00 | 0.00 | 0.01 | 0.02 | 0.902 | 350 | 0.00 | -0.028 | -0.044 | 0.002 |
| put | 36.50 | 0.00 | 2.13 | 0.07 | 0.841 | 119 | 0.00 | -0.022 | -0.034 | 0.002 |
| put | 37.00 | 0.00 | 0.72 | 0.01 | 0.758 | 395 | 20.00 | -0.024 | -0.034 | 0.002 |
| put | 37.50 | 0.00 | 0.02 | 0.02 | 0.678 | 182 | 39.00 | -0.040 | -0.047 | 0.003 |
| put | 38.00 | 0.00 | 0.06 | 0.03 | 0.626 | 209 | 1.00 | -0.047 | -0.050 | 0.003 |
| put | 38.50 | 0.00 | 0.50 | 0.05 | 0.612 | 371 | 1.00 | -0.084 | -0.084 | 0.004 |
| put | 39.00 | 0.01 | 0.06 | 0.03 | 0.516 | 482 | 64.00 | -0.091 | -0.073 | 0.005 |
| put | 39.50 | 0.02 | 0.05 | 0.05 | 0.418 | 729 | 6.00 | -0.138 | -0.091 | 0.006 |
| put | 40.00 | 0.07 | 0.10 | 0.08 | 0.408 | 725 | 116 | -0.217 | -0.117 | 0.009 |
| put | 40.50 | 0.11 | 0.23 | 0.30 | 0.408 | 885 | 221 | -0.319 | -0.130 | 0.010 |
| put | 41.00 | 0.24 | 0.42 | 0.38 | 0.403 | 475 | 111 | -0.463 | -0.138 | 0.012 |
| put | 41.50 | 0.53 | 0.67 | 1.00 | 0.378 | 187 | 1.00 | -0.627 | -0.121 | 0.011 |
| put | 42.00 | 0.88 | 1.40 | 1.62 | 0.747 | 314 | 8.00 | -0.712 | -0.143 | 0.010 |
| put | 42.50 | 1.22 | 2.64 | 2.16 | 1.358 | 87.00 | 0.00 | -0.724 | -0.201 | 0.010 |
| put | 43.00 | 1.58 | 2.40 | 2.40 | 1.028 | 743 | 2.00 | -0.847 | -0.114 | 0.007 |
| put | 43.50 | 2.04 | 3.40 | 3.10 | 1.650 | 167 | 0.00 | -0.843 | -0.147 | 0.007 |
| put | 44.00 | 2.57 | 4.05 | 2.94 | 1.928 | 210 | 0.00 | -0.902 | -0.100 | 0.005 |
| put | 44.50 | 3.20 | 4.60 | 4.14 | 2.108 | 20.00 | 0.00 | -0.936 | -0.071 | 0.004 |
| put | 45.00 | 2.65 | 5.05 | 4.72 | 2.187 | 96.00 | 0.00 | -0.964 | -0.043 | 0.002 |
| put | 45.50 | 4.15 | 5.60 | 5.06 | 2.359 | 1.00 | 0.00 | -0.985 | -0.019 | 0.001 |
| put | 46.00 | 4.05 | 6.10 | 6.41 | 2.478 | 2.00 | 0.00 | -0.986 | -0.020 | 0.001 |
| put | 46.50 | 5.15 | 6.60 | 6.06 | 2.593 | 1.00 | 0.00 | -0.987 | -0.020 | 0.001 |
| put | 47.00 | 5.05 | 7.10 | 6.68 | 2.704 | 2.00 | 0.00 | -0.988 | -0.020 | 0.001 |
| put | 48.00 | 6.65 | 8.10 | 7.61 | 2.919 | 2.00 | 0.00 | -0.989 | -0.021 | 0.001 |
| put | 49.00 | 7.60 | 9.10 | 0.00 | 3.123 | 0.00 | 0.00 | -0.990 | -0.021 | 0.001 |
| put | 50.00 | 8.65 | 10.10 | 9.36 | 3.317 | 0.00 | 0.00 | -0.991 | -0.022 | 0.001 |
| put | 51.00 | 9.60 | 11.10 | 0.00 | 3.503 | 0.00 | 0.00 | -0.991 | -0.022 | 0.001 |
| put | 52.00 | 10.65 | 12.10 | 0.00 | 3.682 | 0.00 | 0.00 | -0.992 | -0.022 | 0.001 |
| put | 55.00 | 13.65 | 15.10 | 0.00 | 4.180 | 0.00 | 0.00 | -0.993 | -0.023 | 0.001 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-09 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-11-09 | SEC |
| 2026-11-05 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-11-05 | SEC |
| 2026-11-04 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-30 | SEC |
| 2026-11-03 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-11-03 | SEC |
| 2026-10-26 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-26 | SEC |
| 2026-10-19 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-19 | SEC |
| 2026-10-13 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2023-10-12 | SEC |
| 2026-10-06 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-05 | SEC |
| 2026-10-05 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-02 | SEC |
| 2026-09-28 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-28 | SEC |
| 2026-09-21 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-21 | SEC |
| 2026-09-17 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-17 | SEC |
| 2026-09-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-14 | SEC |
| 2026-09-09 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-07 | SEC |
| 2026-08-31 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-31 | SEC |
| 2026-08-24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-24 | SEC |
| 2026-08-18 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-17 | SEC |
| 2026-08-10 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-10 | SEC |
| 2026-08-10 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-06 | SEC |
| 2026-08-04 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-04 | SEC |
| 2026-08-04 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-04 | SEC |
| 2026-08-04 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-30 | SEC |
| 2026-07-31 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-31 | SEC |
| 2026-07-27 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-27 | SEC |
| 2026-07-21 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-20 | SEC |
| 2026-07-13 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-13 | SEC |
| 2026-07-06 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-06 | SEC |
| 2026-06-29 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-29 | SEC |
| 2026-06-24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-22 | SEC |
| 2026-06-22 | 11-K | Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | 2025-12-31 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| DODGE & COX | 0.61% |
| LOOMIS SAYLES & CO L P | 0.55% |
| FRANKLIN RESOURCES INC | 0.39% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.35% |
| MORGAN STANLEY | 0.35% |
| BANK OF AMERICA CORP /DE/ | 0.33% |
| Capital International Investors | 0.29% |
| FOLKETRYGDFONDET | 0.28% |
| GOLDMAN SACHS GROUP INC | 0.27% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.25% |
Funds
| Fund | % owned |
|---|---|
| Dodge & Cox Stock Fund | 0.45% |
| Putnam Large Cap Value Fund | 0.24% |
| Washington Mutual Investors Fund | 0.16% |
| Loomis Sayles Growth Fund | 0.15% |
| American Balanced Fund | 0.14% |
| T. Rowe Price International Stock Fund | 0.08% |
| Putnam Focused Large Cap Value ETF | 0.06% |
| ALGER FOCUS EQUITY FUND | 0.05% |
| T. Rowe Price Equity Income Fund | 0.05% |
| Amana Growth Fund | 0.05% |
OakChart. NVO. Cached 15 minutes.
Some panels did not load: insider.